ING5 and lung carcinoma: In lung cancer, ING5 overexpression inhibits the epithelial-to-mesenchymal transition (EMT) by promoting phosphorylation‐dependent degradation of β‐catenin, leading to downregulation of WNT/β‐catenin signaling [21].